Immunology and Vaccine Development Media Coverage

Search and Filter
Filter by date Filter by date
Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
  • all

How to sign up for Seattle-area COVID vaccine trials

Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.

KING 5
November 10, 2020

Roll up your sleeve to fight COVID-19: 3 new vaccine trials will start soon in the Seattle area

Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area. 

The Seattle Times
November 09, 2020

Why volunteer for a vaccine study? Duty, love and a willingness to experiment, participants say

Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.

USA Today
September 04, 2020

Immunology institute founded by Paul Allen shifts focus to tackle coronavirus

Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.

The Seattle Times
August 15, 2020

Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights

Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire. 

GeekWire
August 13, 2020

Q&A: Millions of volunteers needed for COVID-19 vaccine trials

Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more. 

Healio
July 29, 2020

On eve of first big coronavirus vaccine study, trial leaders brace for 'unprecedented' task

Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development. 

Biopharma Dive
July 24, 2020

Help wanted: Volunteers for COVID vaccine trials

Dr. Jim Kublin explained the CoVPN network, and the goals of the program. 

WebMD
July 17, 2020

Fred Hutch to lead COVID-19 vaccine trials

The CoVPN announcement is covered by KING 5.

KING 5
July 09, 2020

First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'

Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.

KOMO News
July 09, 2020

COVID-19 vaccine trials now open to volunteers in U.S.

Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials. 

Forbes
July 08, 2020

Here's how to volunteer for a COVID-19 vaccine trial

CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead. 

CNN
July 08, 2020

Fred Hutch studies immune response to COVID-19, needs participants

Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus. 

KIRO 7
June 28, 2020

The race to make vaccines faster

Andy McGuire commented on the vaccine development process in reference to COVID-19 vaccine research.

Axios
April 23, 2020

Dr. Julie McElrath on lifting physical distancing measures

Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures. 

KOMO Radio
March 26, 2020

Protecting against RSV

Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering. 

Reader's Digest
May 29, 2019

Genetically engineered immune cells fight off deadly virus in mice

Science covered a B cell engineering study led by Dr. Justin Taylor. 

Science
May 17, 2019

Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study

GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses. 

GeekWire
May 17, 2019

Local researchers progressing on malaria vaccine

Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center

The Seattle Channel
March 16, 2017

Local researchers progressing on malaria vaccine

Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center

The Seattle Channel
March 16, 2017

Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease

A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine

GeekWire
January 04, 2017

New vaccine candidate could be the next step toward eliminating malaria

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine

Puget Sound Business Journal
January 04, 2017

Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine

The Seattle Times
January 04, 2017

Volunteers get bit to test new strategy for malaria vaccine

Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh

Associated Press
January 04, 2017

A genetically modified malaria vaccine has passed an important hurdle

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine

MIT Technology Review
January 04, 2017

Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease

A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine

GeekWire
January 04, 2017

New vaccine candidate could be the next step toward eliminating malaria

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine

Puget Sound Business Journal
January 04, 2017

Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine

The Seattle Times
January 04, 2017

Volunteers get bit to test new strategy for malaria vaccine

Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh

Associated Press
January 04, 2017

A genetically modified malaria vaccine has passed an important hurdle

A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine

MIT Technology Review
January 04, 2017

An inside look at the labs where doctors intentionally infect people with malaria

Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch

Business Insider
November 03, 2016

An inside look at the labs where doctors intentionally infect people with malaria

Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch

Business Insider
November 03, 2016

The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope

Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others

The Seattle Times
July 18, 2016

The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope

Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others

The Seattle Times
July 18, 2016

The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope

Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others

The Seattle Times
July 18, 2016

Charlie Sheen's HIV not likely a death sentence

Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division

Newsmax Health
November 17, 2015

Charlie Sheen's HIV not likely a death sentence

Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division

Newsmax Health
November 17, 2015